A pre-IND meeting is scheduled for the first week in October. Each week, highlights of what is going on at FDA are shared to assure that new information is expeditiously made available. The product was recently approved. One of the investigators was Dr. Richard Pazdur who now heads the Oncology Division at FDA . It is estimated that this year about 130,000 people in the US will be diagnosed with colorectal cancer.
Primary treatment consists of surgery with or without adjuvant chemotherapy or radiation.
About half the people treated this way will progress to metastatic disease. In 1996, Camptosar was granted accelerated approval for treatment of patients with metastatic carcinoma of the colon or rectum whose disease had recurred or progressed following 5-FU therapy. Let us be of help to you on your next project. Copyright 1997-1999 Target Health Inc.